Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma [Phase 3]
Phase 3 trial S9922 evaluating combination chemotherapy with filgrastim, with or without thalidomide, for refractory multiple myeloma has be…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis [Phase 2]
Phase 2 SWOG trial evaluating dexamethasone plus interferon alfa in AL amyloidosis has completed enrollment. The update does not provide det…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma [Phase 3]
Phase 3 trial evaluating bortezomib as consolidation therapy in multiple myeloma has completed; the update does not provide trial outcomes.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease
SWOG's S0334 trial, which analyzes chromosomal abnormalities in patients with newly diagnosed multiple myeloma and other blood diseases, has…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma [Phase 3]
The Phase 3 SWOG-9321 trial comparing high-dose melphalan with total body irradiation and transplant versus combination chemotherapy in untr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma [Phase 3]
This is a Phase 3 trial update showing completion of consolidation therapy with bortezomib in elderly patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma [Phase 3]
Phase 3 trial comparing Revlimid (lenalidomide) plus dexamethasone versus dexamethasone alone in previously treated multiple myeloma; result…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myeloma [Phase 2]
Phase 2 trial of pomalidomide in gene expression profiling-defined high-risk multiple myeloma has completed; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization [NA]
This terminated study evaluated hyperbaric oxygen therapy plus standard growth factor support for hematopoietic progenitor/stem cell mobiliz…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Panobinostat/Velcade in Multiple Myeloma [Phase 1]
A phase 1 study evaluating panobinostat in combination with Velcade (bortezomib) for multiple myeloma was terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy [Phase 3]
Phase 3 trial evaluated whether antibiotic therapy reduces early infections in patients with multiple myeloma undergoing chemotherapy; the s…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT [Phase 2]
Phase 2 clinical trial evaluating reduced intensity total body irradiation plus Thymoglobulin followed by allogeneic peripheral blood stem c…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: A Trial of TBL12 Sea Cucumber Extract in Patients With Untreated Asymptomatic Myeloma [Phase 2]
A Phase 2 trial evaluating TBL12 Sea Cucumber Extract in untreated asymptomatic myeloma was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma [EARLY_Phase 1]
An EARLY Phase 1 clinical trial update reports on using filgrastim to treat patients with bortezomib-, carfilzomib-, or IMID-refractory mult…
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY [Phase 1, Phase 2]
This update covers an allogeneic bone marrow transplant using matched related or unrelated donors with FluBu conditioning and HiCy (high-dos…
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma [Phase 1]
This Phase 1 trial evaluated the cardiac effects of siltuximab in patients with Monoclonal Gammopathy of Undetermined Significance and Multi…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Imaging in MGUS, SMM and MM [Phase 2]
Completed Phase 2 clinical trial evaluating imaging in monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and …
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients [Phase 2]
Phase 2 safety and PK/PD study of TG-0054 in patients with multiple myeloma, non-Hodgkin lymphoma, and Hodgkin disease has completed with re…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen [Phase 1, Phase 2]
This completed Phase 1/2 clinical trial evaluated a conditioning regimen using Clofarabine and Busulfan for hematologic malignancies, includ…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating bortezomib combined with liposomal doxorubicin, dexamethasone, and cyclophosphamide in multiple myeloma that relaps…
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma [Phase 2]
Phase 2 clinical trial update for SyB L-0501 in Relapsed/Refractory Multiple Myeloma; the study has completed and results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease [Phase 2]
Phase 2 trial evaluating TG-0054 alone or with G-CSF in multiple myeloma and lymphomas; completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: PAD. ICORG 05-01, V11 [Phase 2]
Phase 2 trial ICORG 05-01 for multiple myeloma and plasma cell neoplasm has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma [Phase 3]
Phase 3 companion study update for multiple myeloma trials, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2014-12-24Clinical Trial Update: Skin Biopsies in Chemotherapy-Induced Neuropathy
This completed clinical trial evaluated skin biopsies as a biomarker for chemotherapy-induced peripheral neuropathy in patients with multipl…